Spring Pharmaceutical Group, Inc. (CYIG) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
11 QUANXING ROAD SICHUI, 273200 |
| State of Incorp. | FL |
| Fiscal Year End | March 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 10,309 | 7,639 | 13,084 | 18,625 | 29,924 | |||
| Cash and cash equivalents | 10,309 | 7,639 | 13,084 | 18,625 | 29,924 | |||
| Receivables | 1,135 | 533 | 96 | 42 | 135 | |||
| Inventory, net of allowances, customer advances and progress billings | 5,483 | 2,287 | 897 | 1,593 | 1,297 | |||
| Inventory | 5,483 | 2,287 | 897 | 1,593 | 1,297 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 21 | ||
| Other undisclosed current assets | 1,551 | 962 | 686 | 360 | ||||
| Total current assets: | 18,478 | 11,421 | 14,762 | 20,619 | 31,377 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 14,487 | 12,873 | 12,864 | 13,385 | 9,410 | |||
| Intangible assets, net (including goodwill) | 12,043 | 12,295 | 15,393 | 16,684 | 17,657 | |||
| Intangible assets, net (excluding goodwill) | 12,043 | 12,295 | 15,393 | 16,684 | 17,657 | |||
| Other undisclosed noncurrent assets | 45,279 | 44,726 | 34,139 | 16,532 | 221 | |||
| Total noncurrent assets: | 71,809 | 69,894 | 62,396 | 46,601 | 27,287 | |||
| TOTAL ASSETS: | 90,287 | 81,316 | 77,158 | 67,220 | 58,664 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 251 | 190 | 145 | 817 | 887 | |||
| Taxes payable | 2,028 | 739 | 1,603 | 817 | 887 | |||
| Other undisclosed accounts payable and accrued liabilities | (1,777) | (549) | (1,458) | |||||
| Other liabilities | 30 | 367 | ||||||
| Due to related parties | 706 | |||||||
| Other undisclosed current liabilities | 2,028 | 776 | 1,603 | |||||
| Total current liabilities: | 2,986 | 966 | 1,748 | 846 | 1,254 | |||
| Noncurrent Liabilities | ||||||||
| Other undisclosed noncurrent liabilities | 2,423 | |||||||
| Total noncurrent liabilities: | 2,423 | |||||||
| Total liabilities: | 5,409 | 966 | 1,748 | 846 | 1,254 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | 87,301 | 80,350 | 75,409 | 66,374 | 57,411 | |||
| Preferred stock | 23 | 23 | 23 | 23 | 23 | |||
| Common stock | 30 | 30 | 30 | 30 | 30 | |||
| Additional paid in capital | 4,323 | 4,648 | 4,210 | 4,180 | 4,180 | |||
| Accumulated other comprehensive income (loss) | (4,387) | 837 | 4,752 | 4,637 | 3,795 | |||
| Retained earnings | 84,890 | 74,812 | 66,395 | 57,505 | 49,384 | |||
| Other undisclosed equity, attributable to parent | 2,423 | |||||||
| Equity, attributable to noncontrolling interest | ||||||||
| Other undisclosed equity | (2,423) | (0) | ||||||
| Total equity: | 84,878 | 80,350 | 75,409 | 66,374 | 57,411 | |||
| TOTAL LIABILITIES AND EQUITY: | 90,287 | 81,316 | 77,158 | 67,220 | 58,664 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 56,463 | 47,827 | 37,943 | 34,063 | 33,103 | ||
| Revenue, net | 134 | 47,827 | 34,063 | 33,103 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (33,284) | (26,554) | (20,023) | (17,407) | (17,303) | ||
| Other undisclosed gross profit | 1,449 | 1,273 | 1,126 | ||||
| Gross profit: | 23,179 | 21,273 | 19,370 | 17,928 | 16,925 | ||
| Operating expenses | (9,978) | (10,046) | (7,571) | (7,210) | (7,742) | ||
| Operating income: | 13,201 | 11,227 | 11,799 | 10,718 | 9,183 | ||
| Nonoperating income (expense) (Investment Income, Nonoperating) | 55 | 31 | (86) | ||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 172 | 79 | 8,404 | ||||
| Income from continuing operations before income taxes: | 13,255 | 11,258 | 11,885 | 10,798 | 17,587 | ||
| Income tax expense (benefit) | (3,201) | 2,841 | 2,995 | (2,677) | (2,326) | ||
| Income from continuing operations: | 10,055 | 14,099 | 14,880 | 8,121 | 15,261 | ||
| Income before gain (loss) on sale of properties: | 10,055 | 14,099 | 14,880 | 8,121 | 15,261 | ||
| Net income: | 10,055 | 14,099 | 14,880 | 8,121 | 15,261 | ||
| Net income attributable to noncontrolling interest | 24 | ||||||
| Other undisclosed net loss attributable to parent | (5,682) | (5,989) | |||||
| Net income attributable to parent: | 10,078 | 8,417 | 8,890 | 8,121 | 15,261 | ||
| Other undisclosed net loss available to common stockholders, basic | |||||||
| Net income available to common stockholders, diluted: | 10,078 | 8,417 | 8,890 | 8,121 | 15,261 | ||
Comprehensive Income ($ in thousands)
| 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | 3/31/2013 | ||
|---|---|---|---|---|---|---|---|
| Net income: | 10,055 | 14,099 | 14,880 | 8,121 | 15,261 | ||
| Other undisclosed comprehensive income (loss) | (5,200) | ||||||
| Comprehensive income: | 4,854 | 14,099 | 14,880 | 8,121 | 15,261 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 28 | ||||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (56) | (9,597) | (5,874) | 842 | 454 | ||
| Comprehensive income, net of tax, attributable to parent: | 4,826 | 4,502 | 9,005 | 8,963 | 15,715 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.